Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) Versus Non-ICIs in Chinese Patients

NCT06522048 is registered in ClinicalTrials.gov with Chao Ji as lead sponsor.

NCT NCT06522048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06522048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) Versus Non-ICIs in Chinese Patients
Lead sponsor
Chao Ji
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
May 31, 2024
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune checkpoint inhibitor-induced dermatitis, stevens-johnson syndrome, drug-induced, toxic epidermal necrolysis due to drug